Our cross-sectional study clearly demonstrated that SARS-CoV-2 specific IL-2-producing T cells are maintained up to 12 months after vaccination or infection, although antibody levels and IFN-γ-producing T cells decline over time in allogeneic HCT recipients. The gene discussed is IL2; the disease is infection.